Icon

Achillion Pharmaceuticals, Inc Stock Analysis and Price Target COMMON STOCK | Advertising Agencies | NSD

stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 110.00

0.00 (0.00)%

USD 0.02B

30.00

N/A

N/A

Icon

ACHN

Achillion Pharmaceuticals, Inc (USD)
COMMON STOCK | NSD
USD 110.00
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.02B

N/A

USD 110.00

Achillion Pharmaceuticals, Inc Stock Forecast

N/A

Based on the Achillion Pharmaceuticals, Inc stock forecast from 0 analysts, the average analyst target price for Achillion Pharmaceuticals, Inc is not available over the next 12 months. Achillion Pharmaceuticals, Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Achillion Pharmaceuticals, Inc is Very Bearish, which is based on 0 positive signals and 1 negative signals. At the last closing, Achillion Pharmaceuticals, Inc’s stock price was USD 110.00. Achillion Pharmaceuticals, Inc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +0.00% over the last year.

No recent analyst target price found for Achillion Pharmaceuticals, Inc
No recent average analyst rating found for Achillion Pharmaceuticals, Inc

Company Overview Achillion Pharmaceuticals, Inc

Achison Inc. focuses on operating online advertising business through www.dazhong368.com in the New York area, the United States. Its Website advertises various markets for professional individuals or companies, including real estate, services, accounting, and legal. The company ...Read More

http://www.achillion.com

300 George Street 06511,New Haven,USA

0

December

USD

USA

Adjusted Closing Price for Achillion Pharmaceuticals, Inc (ACHN)

Loading...

Unadjusted Closing Price for Achillion Pharmaceuticals, Inc (ACHN)

Loading...

Share Trading Volume for Achillion Pharmaceuticals, Inc Shares

Loading...

Compare Performance of Achillion Pharmaceuticals, Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ACHN

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Achillion Pharmaceuticals, Inc (Sector: Advertising Agencies )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ZD
Ziff Davis Inc -0.71 (-1.08%) USD3.01B 65.56 6.40

ETFs Containing ACHN

Symbol Name ACHN's Weight Expense Ratio Price(Change) Market Cap

Frequently Asked Questions About Achillion Pharmaceuticals, Inc (ACHN) Stock

Stock Target Advisor's fundamental analysis for Achillion Pharmaceuticals, Inc's stock is Very Bearish.

Unfortunately we do not have enough data on ACHN's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on ACHN's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on ACHN's stock to indicate if its overvalued.

The last closing price of ACHN's stock was USD 110.00.

The most recent market capitalization for ACHN is USD 0.02B.

Unfortunately we do not have enough analyst data on ACHN's stock to indicate whether its price will go up or not.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...